Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ESLICARBAZEPINE ACETATE
- Clinical Trial for Zebinix (Eslicarbazepine Acetate) in Healthy Korean and Caucasian Adult
- A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures
- A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
- Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults
- Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers
- Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors
- Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures
- Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate
- Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate
- Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine
- Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function
- Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate Versus To-be-marketed Formulation
- Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.
- A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate
- Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.
- Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization
- Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine
- An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093
- Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites
- Pharmacokinetics, Efficacy and Tolerability of BIA 2-093
- Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours
- A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy Volunteers
- A Sequential Multiple Ascending Dose Study of the Safety and Pharmacokinetics of Eslicarbazepine Acetate in Adult Healthy Volunteers
- The Effect of BIA 2-093 on the Steady-state Pharmacokinetic Profile of Phenytoin in Patients
- A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)
- Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder
- Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
- Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
- Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia
- Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine
- Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
- Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)
- Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures
- Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients
- Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures
- Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain
- Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia
- Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic
- Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
- Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
- Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects
- Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia
- Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy
- Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers
- Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures
- Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
- Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy
- Eslicarbazepine Acetate Monotherapy Long Term Study
- Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
- Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive
- Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Clinical trials list
click for details